六块爱理不理 8块高攀不起查看全文
格隆汇11月15日丨Aytu BioPharma(AYTU.US)盘前涨18.76%,报0.23美元。公司2023年Q1财报实现营收2765.5万美元,前值为2189.7万美元,预期值为2430万美元,超出市场预期13.81%;每股收益为-0.06美元,前值为-0.33美元,预期值为-0.18美元,超出市场预期66.67%。 网页链接
$Aytu BioScience(AYTU)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-20-001463 Act: 33 Size: 1 KB 网页链接
$Aytu BioScience(AYTU)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-20-001464 Act: 33 Size: 1 KB 网页链接
$Aytu BioScience(AYTU)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001654954-20-006583 Size: 6 KB 网页链接
$Aytu BioScience(AYTU)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001654954-20-006584 Size: 5 KB 网页链接
$Aytu BioScience(AYTU)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001654954-20-006585 Size: 6 KB 网页链接
$Aytu BioScience(AYTU)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001654954-20-006581 Size: 5 KB 网页链接
$Aytu BioScience(AYTU)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001654954-20-006582 Size: 6 KB 网页链接
$Aytu BioScience(AYTU)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001654954-20-006576 Size: 5 KB 网页链接
$Aytu BioScience(AYTU)$ 8-K Current report, item 8.01 Accession Number: 0001213900-20-014833 Act: 34 Size: 22 KB 网页链接
$Aytu BioScience(AYTU)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001213900-20-014381 Act: 33 Size: 1 MB 网页链接